Varia genera morborum haemorrhagicorum sunt, quae praecipue secundum aetiologiam et pathogenesin clinicē digeruntur. Dividi possunt in vascularia, thrombocytaria, anomalias factorum coagulationis, et cetera.
1. Vasculare:
(1) Hereditarius: telangiectasia hereditaria, haemophilia vascularis, et textus sustentans abnormalis circa vasa sanguinea;
(2) Acquisita: laesio parietis vascularis causata a purpura allergica, purpura simplici, purpura medicamentis inducta, purpura aetate relata, purpura autoimmuni, infectione, factoribus metabolicis, factoribus chemicis, factoribus mechanicis, etc.
2. Proprietates thrombocytorum:
(1) Thrombocytopenia: thrombocytopenia immunis, thrombocytopenia medicamentis inducta, anaemia aplastica, infiltratio tumoris, leucaemia, morbi immunes, CID, hyperfunctio splenica, purpura thrombotica thrombocytopenica, etc.;
(2) Thrombocytosis: Thrombocytosis primaria, polycythaemia vera, splenectomia, tumor, dysfunctio thrombocytaria inflammatoria, thrombocytopenia, syndroma thrombocytariorum gigantum, morbus hepaticus, et dysfunctio thrombocytaria ab uraemia causata.
3. Factores coagulationis abnormales:
(1) Anomaliae hereditariae factorum coagulationis: haemophilia A, haemophilia B, defectus FXI, FV, FXI, FVII, FVIII, fibrinogeni congeniti humilis (absens), defectus prothrombini, et defectus factorum coagulationis complexorum;
(2) Anomaliae factorum coagulationis acquisitae: morbus hepaticus, defectus vitaminae K, leucaemia acuta, lymphoma, morbus textus connectivi, etc.
4. Hyperfibrinolysis:
(1) Primaria: Defectus hereditarius inhibitorum fibrinolyticorum vel aucta activitas plasminogeni facile hyperfibrinolysim in morbis hepaticis gravibus, tumoribus, chirurgiae et traumatibus inducere potest;
(2) Acquisita: visibilis in thrombosi, DIC, et morbo hepatico gravi (secundario)
Incrementum pathologicum substantiarum circulantium, inhibitores acquisiti ut F VIII, FX, F XI, et F XII, morbi autoimmunes, tumores maligni, gradus aucti anticoagulantium heparino similium, et anticoagulantium lupici.
Referentia: [1] Xia Wei, Chen Tingmei. *De Rationibus Examinationis Haematologiae Clinicae*. Editio Sexta [M]. Pechinum. Domus Editoria Salutis Popularis. 2015.
Pechinum SUCCEEDER (https://www.succeeder.com/), ut una ex praecipuis societatibus in foro diagnostico thrombosis et haemostaseos Sinensi, SUCCEEDER peritos greges investigationis et progressionis (R&D), productionis, venditionis mercatus, et servitii habet. Suppeditans analysores et reagentia coagulationis, analysores rheologiae sanguinis, analysores ESR et HCT, analysores aggregationis thrombocytorum cum certificatione ISO13485, CE, et ab FDA enumeratis.
Charta negotialis
WeChat Sinensis